Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 19 studies | 26% ± 9% | |
ciliated cell | 19 studies | 29% ± 12% | |
microglial cell | 12 studies | 37% ± 13% | |
alveolar macrophage | 8 studies | 33% ± 12% | |
endothelial cell | 7 studies | 18% ± 2% | |
conventional dendritic cell | 7 studies | 19% ± 6% | |
epithelial cell | 7 studies | 32% ± 14% | |
dendritic cell | 5 studies | 25% ± 7% | |
monocyte | 5 studies | 31% ± 17% | |
squamous epithelial cell | 4 studies | 34% ± 23% | |
myeloid cell | 4 studies | 31% ± 6% | |
basal cell | 4 studies | 31% ± 7% | |
endothelial cell of lymphatic vessel | 3 studies | 17% ± 2% | |
classical monocyte | 3 studies | 19% ± 3% | |
mononuclear phagocyte | 3 studies | 18% ± 4% | |
enterocyte | 3 studies | 23% ± 4% | |
goblet cell | 3 studies | 25% ± 6% | |
leukocyte | 3 studies | 29% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 5 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1578.57 | 577 / 578 | 97% | 26.89 | 1117 / 1155 |
stomach | 89% | 497.90 | 319 / 359 | 96% | 12.45 | 275 / 286 |
esophagus | 81% | 1238.82 | 1173 / 1445 | 99% | 40.93 | 182 / 183 |
intestine | 85% | 861.86 | 822 / 966 | 94% | 11.87 | 498 / 527 |
uterus | 84% | 326.78 | 143 / 170 | 86% | 18.42 | 395 / 459 |
pancreas | 71% | 265.39 | 232 / 328 | 90% | 9.60 | 161 / 178 |
bladder | 67% | 382.43 | 14 / 21 | 86% | 12.51 | 435 / 504 |
prostate | 98% | 573.27 | 241 / 245 | 53% | 3.85 | 266 / 502 |
kidney | 75% | 320.29 | 67 / 89 | 69% | 5.43 | 623 / 901 |
thymus | 98% | 532.76 | 642 / 653 | 40% | 1.95 | 239 / 605 |
skin | 100% | 1196.56 | 1800 / 1809 | 31% | 3.08 | 148 / 472 |
ovary | 92% | 355.81 | 166 / 180 | 37% | 2.02 | 157 / 430 |
breast | 96% | 720.14 | 439 / 459 | 29% | 2.92 | 322 / 1118 |
muscle | 100% | 2394.00 | 801 / 803 | 0% | 0 | 0 / 0 |
adipose | 95% | 954.50 | 1140 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 27.08 | 40 / 45 |
brain | 31% | 130.93 | 820 / 2642 | 45% | 3.64 | 315 / 705 |
adrenal gland | 54% | 202.29 | 139 / 258 | 13% | 0.99 | 30 / 230 |
peripheral blood | 66% | 552.22 | 612 / 929 | 0% | 0 | 0 / 0 |
liver | 14% | 69.44 | 32 / 226 | 34% | 3.16 | 137 / 406 |
spleen | 43% | 118.66 | 103 / 241 | 0% | 0 | 0 / 0 |
heart | 41% | 155.70 | 352 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 38% | 140.15 | 505 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.38 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016266 | Biological process | O-glycan processing |
GO_0006688 | Biological process | glycosphingolipid biosynthetic process |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0009247 | Biological process | glycolipid biosynthetic process |
GO_0006486 | Biological process | protein glycosylation |
GO_0007417 | Biological process | central nervous system development |
GO_0000139 | Cellular component | Golgi membrane |
GO_0008499 | Molecular function | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008532 | Molecular function | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity |
GO_0047256 | Molecular function | lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity |
Gene name | B3GNT5 |
Protein name | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase (EC 2.4.1.206) (Lactotriaosylceramide synthase) (Lc(3)Cer synthase) (Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5) (BGnT-5) (Beta-1,3-Gn-T5) (Beta-1,3-N-acetylglucosaminyltransferase 5) (Beta3Gn-T5) |
Synonyms | |
Description | FUNCTION: Beta-1,3-N-acetylglucosaminyltransferase that plays a key role in the synthesis of lacto- or neolacto-series carbohydrate chains on glycolipids, notably by participating in biosynthesis of HNK-1 and Lewis X carbohydrate structures. Has strong activity toward lactosylceramide (LacCer) and neolactotetraosylceramide (nLc(4)Cer; paragloboside), resulting in the synthesis of Lc(3)Cer and neolactopentaosylceramide (nLc(5)Cer), respectively. Probably plays a central role in regulating neolacto-series glycolipid synthesis during embryonic development. . |
Accessions | ENST00000326505.4 ENST00000465010.1 ENST00000464923.1 C9IYY0 Q9BYG0 C9J368 C9J5K2 ENST00000464191.1 ENST00000481531.1 ENST00000460419.1 |